Patients who took the frequently prescribed diabetes and weight-loss drugs Ozempic and Wegovy faced a greater risk ...
Last summer, doctors at Mass Eye and Ear noticed an unusually high number of patients with non-arteritic anterior ischemic ...
Doctors in Massachusetts have found a link between the drug’s active ingredient semaglutide and a higher risk of a rare ...
People who use Ozempic or Wegovy for treating obesity or Type 2 diabetes may have an increased risk of developing a ...